Mesothelioma is one of the deadliest solid cancers, with few treatment options, all of whi...

Enlivex Presented Substantial Survival Benefit of Allocetra in Combination with Immune Checkpoint Inhibitor in Mesothelioma Cancer Study at the International Society for Cell and Gene Therapy Annual 2022 Meeting – GlobeNewswire

Mesothelioma is one of the deadliest solid cancers, with few treatment options, all of which have limited efficacy. Immune checkpoint inhibitors targeting CTLA4 and PD1 are FDA-approved as a first-line treatments for patients with unresectable…

 

Read the full article here


-- END RSP MOD -->